Oldfield, Edward C. IV MD 1; Johnson, David A. MD, MACG, FASGE, MACP 1; Rex, Douglas K. MD, MACG, MASGE, MACP 2,3
doi : 10.14309/ajg.0000000000002110
Volume 118(5) pgs. 761-913 May 2023
Wolf, Patricia G. PhD, RD 1; Kim, Sage PhD 2; Tussing-Humphreys, Lisa PhD, MS, RD 3
Nahoum, Luiza MD 1; Carpentieri-Primo, Pedro MD 1; Parente, Daniella Braz MD, PhD 1,2
Shirata, Chikara MD 1; Demartines, Nicolas MD, FACS, FRCS 1; Matter, Maurice MD 1; Joliat, Gaetan-Romain MD 1
Kawasaki, Keisuke MD 1; Kawatoko, Shinichiro MD 1,2; Yamamoto, Hidetaka MD 2; Torisu, Takehiro MD 1
Mazza, Stefano MD 1; Drago, Andrea MD 1; Tanzi, Giulia MD 2; Soro, Sara MD 1; Verga, Maria Chiara MD 1; Elvo, Biagio MD 1; Laurenza, Carmen MD 1; di Luna, Imma MD 1; Grassia, Roberto MD 1
Chittajallu, Vibhu MD 1; Vozzo, Catherine DO 1; Friedman, Kenneth MD 2; Glessing, Brooke MD 1; Nguyen, Vu MD 1
Tsiamoulos, Zacharias P. MBBS, MD(Res), PhD 1; Basit, Rizwan MBBS, BSc (Hons), FRCR 2; Vega, Roser LMC, PhD 3; Beintaris, Iosif MBBS 4; Ramchandani, Mohan MD, PhD 5; Sebastian, Joseph MBBS, MS, MRCS, FRCS 6; Saunders, Brian P. MBBS, MD, FRCP, FRCS 7
Holzwanger, Erik A. MD
doi : 10.14309/ajg.0000000000002271
AB Article Title: Reduced Adenoma Miss Rate with 9-Minute vs 6-Minute Withdrawal Times for Screening Colonoscopy: A Multicenter Randomized Tandem Trial (C) The American College of Gastroenterology 2023. All Rights Reserved.
Khan, Zubair MD
doi : 10.14309/ajg.0000000000002272
AB Article Title: Linaclotide Reduced Response Time for Irritable Bowel Syndrome with Constipation Symptoms: Analysis of Four Randomized Controlled Trials (C) The American College of Gastroenterology 2023. All Rights Reserved.
Sauer, Bryan G. MD, MSc, FACG 1; Barnes, Barrett H. MD 2; McGowan, Emily C. MD, PhD 3
Jansson-Knodell, Claire L. MD 1; Rubio-Tapia, Alberto MD 1
Wong, Ming-Wun MD, PhD 1,2; Hsiao, Shih-Hsuan MD 3; Wang, Jen-Hung PhD 4; Yi, Chih-Hsun MD 1; Liu, Tso-Tsai MD 1; Lei, Wei-Yi MD, PhD 1; Hung, Jui-Sheng MD 1; Liang, Shu-Wei MD 1; Lin, Lin MD 1; Gyawali, Chandra Prakash MD 5; Chen, Peir-Rong MD 3; Chen, Chien-Lin MD, PhD 1,6
doi : 10.14309/ajg.0000000000002151
Laryngopharyngeal reflux (LPR) is a clinical conundrum without a diagnostic gold standard. The Esophageal Hypervigilance and Anxiety Scale (EHAS) is a questionnaire designed for cognitive-affective evaluation of visceral sensitivity.
Visaggi, Pierfrancesco MD 1,2; Del Corso, Giulio MD 3; Gyawali, C. Prakash MD 4; Ghisa, Matteo MD 5; Baiano Svizzero, Federica MD 1; Stefani Donati, Delio MD 1; Venturini, Arianna MD 1; Savarino, Vincenzo MD 6; Penagini, Roberto MD 7; Zeki, Sebastian MD, PhD 2,8; Bellini, Massimo MD 1; Savarino, Edoardo V. MD, PhD 5,*; de Bortoli, Nicola MD 1,*
doi : 10.14309/ajg.0000000000002173
The Lyon Consensus designates Los Angeles (LA) grade C/D esophagitis or acid exposure time (AET) >6% on impedance-pH monitoring (MII-pH) as conclusive for gastroesophageal reflux disease (GERD).
Zhao, Shengbing MD 1,*; Song, Yihang MD 1,*; Wang, Shuling MD 1,*; Wang, Rong MD 2,*; Feng, Zhijie MD 3,*; Gong, Aixia MD 4,*; Yang, Xia MD 5,*; Pan, Peng MD 1; Yao, Dongmei MD 3; Zhang, Jingwen MD 4; Zhu, Yaqin MD 5; Li, Tao MD 2; Bi, Junhua MD 2; Ren, Xu MD 6; Tang, Xiufen MD 6; Li, Qiang MD 6; Yu, Dan MD 6; Zheng, Jinghua MD 7; Song, Bo MD 7; Wang, Ping MD 7; Chen, Weigang MD 8; Shang, Guochen MD 8; Xu, Yanqiu MD 8; Xu, Ping MD 9; Lai, Yuexing MD 9; Xu, Huanhai MD 10; Yang, Xiaomin MD 10; Sheng, Jianqiu MD 11; Tao, Yurong MD 11; Li, Xinghua MD 12; Zhu, Yangbei MD 12; Zhang, Xiaofeng MD 13; Shen, Hongzhang MD 13; Ma, Yingcai MD 14; Wang, Fangyu MD 15; Wu, Lin MD 15; Wang, Xianfei MD 16; Li, Zhaoshen MD, PhD 1; Bai, Yu MD, PhD 1
doi : 10.14309/ajg.0000000000002055
Although the 9-minute mean withdrawal time (m-WT) is often reported to be associated with the optimal adenoma detection rate (ADR), no randomized trials of screening colonoscopy have confirmed the impact of a 9-minute m-WT on adenoma miss rate (AMR) and ADR.
Hansen-Barkun, Christopher BKin 1; Martel, Myriam MSc 1; Douketis, James MD 2; Abraham, Neena S. MD, MSc (Epi), MACG 3; Liederman, Zachary MD 4; Kaplovitch, Eric MD 5; Schulman, Sam MD, PhD 6,7; Spyropoulos, Alex C. MD 8,9; Majid, Almadi MD, MSc 10; Barkun, Alan N. MD 11
doi : 10.14309/ajg.0000000000002076
The periprocedural management of patients with atrial fibrillation (AF) using a direct oral anticoagulant (DOAC) undergoing elective gastrointestinal (GI) endoscopic procedure remains uncertain.
Yoosuf, Shakira MD 1,2; Singh, Prashant MD 3; Khaitan, Ashank MBBS 1; Strand, Tor A. MD 4; Ahuja, Vineet MD, DM 1; Makharia, Govind K. MD, DM, DNB 1
doi : 10.14309/ajg.0000000000002123
A subset of patients with celiac disease (CeD) has liver involvement in the form of hypertransaminasemia, liver cirrhosis, and autoimmune hepatitis. We conducted a systematic review with meta-analyses to determine the pooled prevalence of CeD in patients with cryptogenic cirrhosis, all-cause cirrhosis, cryptogenic hypertransaminasemia, and all-cause hypertransaminasemia.
Gupta, Anany MD 1,*; Rana, Randeep MD 1,*; Agarwal, Samagra MD, DM 1,*; Sharma, Sanchit MD, DM 1,2,**; Gopi, Srikanth MD, DM 1; Mohta, Srikant MD, DM 1; Gunjan, Deepak MD, DM 1; Saraya, Anoop MD, DM, DNB 1,**
doi : 10.14309/ajg.0000000000002018
Limited data exist on long-term outcomes of patients with compensated cirrhosis presenting with acute variceal bleeding (AVB) as an index and lone decompensating event.
Lee, Chul-min MD, PhD 1,*; Yoon, Eileen L. MD, PhD 2,*; Nakajima, Atsushi MD, PhD 3; Yoneda, Masato MD, PhD 3; Toyoda, Hidenori MD, PhD 4; Yasuda, Satoshi MD, PhD 4; Lee, Jonghyun PhD 5; Kim, Mimi MD, PhD 1; Kang, Bo-Kyeong MD, PhD 1; Nguyen, Mindie H. MD, PhD 6; Jun, Dae Won MD, PhD 2,5; Sumida, Yoshio MD, PhD 7
doi : 10.14309/ajg.0000000000002020
Previous studies have shown that ultrasonography has high specificity (80%-100%) but low sensitivity (50%-70%) in diagnosing fatty liver; sensitivity is especially low for mild steatosis. In this study, we aimed to reappraise the diagnostic performance of B-mode ultrasonography (B-USG) for fatty liver disease.
Heuthorst, Lianne MD 1; Harbech, Houda BSc 1; Snijder, Harmanna J. MD 1,2,3,4; Mookhoek, Aart MD, PhD 5; D'Haens, Geert R. MD, PhD 2; Vermeire, Severine MD, PhD 3; D'Hoore, Andre MD, PhD 4; Bemelman, Willem A. MD, PhD 1; Buskens, Christianne J. MD, PhD 1
doi : 10.14309/ajg.0000000000002099
The aim of the current study was to assess whether there is an indication shift for surgery in patients with ulcerative colitis (UC) from refractory disease to malignant degeneration over the past 3 decades.
Goldowsky, Alexander MD 1; Billings, Wade MD 2; Kickel, Allison BS 3; Charabaty, Aline MD 4
doi : 10.14309/ajg.0000000000002103
MondayNightIBD provides weekly continuing medical education (CME) activities focused on inflammatory bowel diseases to clinicians on Twitter. Given its novelty, we assessed whether @MondayNightIBD improves learner knowledge and leads to practice change.
Ma, Christopher MD, MPH 1,2,3; Panaccione, Remo MD 1; Xiao, Yasi MD 4; Khandelwal, Yuvan BSc 5; Murthy, Sanjay K. MD, MSc 6,7; Wong, Emily C.L. BHSc 8; Narula, Neeraj MD, MPH 8; Tsai, Catherine MD 9; Peerani, Farhad MD 9; Reise-Filteau, Marica MD 10; Bressler, Brian MD, MS 10; Starkey, Samantha Y. BSc 11; Loomes, Dustin MD 12; Sedano, Rocio MD 3; Jairath, Vipul MBChB, DPhil, MRCP 3,13,14; Bessissow, Talat MDCM, MSc 15
doi : 10.14309/ajg.0000000000002129
We aimed to evaluate the real-world effectiveness and safety of tofacitinib for the treatment of ulcerative colitis (UC). METHODS: REMIT-UC is a Canadian multicenter cohort study.
Brenner, Darren M. MD 1; Lacy, Brian E. MD, PhD 2; Ford, Alexander C. MD 3,4; Bartolini, Wilmin PhD 5,6; Wu, James PhD 5; Shea, Elizabeth P. PhD 5,7; Bochenek, Wieslaw MD, PhD 8; Boinpally, Ramesh PhD 8; Almansa, Cristina MD, PhD 5,9
doi : 10.14309/ajg.0000000000002064
These post hoc analyses provide clinically relevant data concerning time to response for individual irritable bowel syndrome with constipation (IBS-C) symptoms after linaclotide use.
Timmerhuis, Hester C. MD 1,2; van Dijk, Sven M. MD, PhD 3,4; Hollemans, Robbert A. MD 5; Sperna Weiland, Christina J. MD, PhD 6; Umans, Devica S. MD 4,7; Boxhoorn, Lotte MD, PhD 4,7; Hallensleben, Nora H. MD 8; van der Sluijs, Rogier MD, PhD 9; Brouwer, Lieke MD, PhD 10; van Duijvendijk, Peter MD, PhD 11; Kager, Liesbeth MD, PhD 12; Kuiken, Sjoerd MD, PhD 13; Poley, Jan-Werner MD, PhD 14; de Ridder, Rogier MD 14; Romkens, Tessa E.H. MD, PhD 15; Quispel, Rutger MD, PhD 16; Schwartz, Matthijs P. MD, PhD 17; Tan, Adriaan C.I.T.L. MD, PhD 18; Venneman, Niels G. MD, PhD 19; Vleggaar, Frank P. MD, PhD 20; van Wanrooij, Roy L.J. MD, PhD 4,21; Witteman, Ben J. MD, PhD 22; van Geenen, Erwin J. MD, PhD 6; Molenaar, I. Quintus MD, PhD 5; Bruno, Marco J. MD, PhD 8; van Hooft, Jeanin E. MD, PhD, MBA 23; Besselink, Marc G. MD, PhD 3,4; Voermans, Rogier P. MD, PhD 4,7; Bollen, Thomas L. MD, PhD 24; Verdonk, Robert C. MD, PhD 20,25,*; van Santvoort, Hjalmar C. MD, PhD 2,5,*; for the Dutch Pancreatitis Study Group
doi : 10.14309/ajg.0000000000002157
Necrotizing pancreatitis may result in a disrupted or disconnected pancreatic duct (DPD) with the potential for long-lasting negative impact on a patient's clinical outcome.
Lee, Hyun Deok MD 1; Lee, Eunwoo MD 1; Kim, Sang Gyun MD, PhD 1; Shin, Cheol Min MD, PhD 2; Park, Jun Chul MD, PhD 3; Choi, Kee Don MD, PhD 4; Hahn, Seokyung PhD 5; Cho, Soo-Jeong MD, PhD 1
doi : 10.14309/ajg.0000000000002172
This study evaluated the efficacy of fibrin glue for preventing postendoscopic submucosal dissection (ESD) bleeding in high-risk patients for bleeding (expected iatrogenic ulcer size >=40 mm or receiving antithrombotic therapy).
Kolb, Jennifer M. MD, MS 1; Davis, Christian MD 2; Williams, J. Lucas MPH 3; Holub, Jennifer MPH 3; Shaheen, Nicholas MD, MPH 4; Wani, Sachin MD 5
doi : 10.14309/ajg.0000000000002102
Variability in adherence rates to the Seattle protocol and to surveillance interval recommendations, established quality indicators (QIs) in Barrett's esophagus (BE), is unknown.
Anderson, Jenna MD 1; Frost, Spencer MD 2; Keyashian, Kian MD 2; Modiano, Nir MD, PhD 1
doi : 10.14309/ajg.0000000000002137
This study evaluates the potential association of pentosan polysulfate (PPS) with inflammatory bowel disease (IBD) or dysplasia. METHODS: We searched electronic medical records to identify patients with IBD using PPS.
Zhang, Heng MD 1; Jiang, Bin PhD 1; Meng, Zhong-ji PhD 1
Dhakre, Vijay Waman MS, FHPB, FMAS 1; Shah, Preet MBBS, DNB 2; Nagral, Sanjay S. MS, FACS 3; Nagral, Aabha S. MD, DNB 4
Schepis, Tommaso MD 1,2; Tringali, Andrea MD, PhD 1,2; Spada, Cristiano MD, PhD 1,2; Costamagna, Guido MD, FACG, FJGES 1,2; Boskoski, Ivo MD, PhD 1,2
Rettally, Carlos MD 1
آیا می خواهید مدیلیب را به صفحه اصلی خود اضافه کنید؟